Hammerman, A., Greenberg-Dotan, S., Battat, E., Feldhamer, I., Bitterman, H., & Brenner, B. (2015). The ‘real-life’ impact of adding bevacizumab to first-line therapy in metastatic colorectal cancer patients: A large Israeli retrospective cohort study. Acta Oncologica, 54(2), 164–170. https://doi.org/10.3109/0284186X.2014.958532